Addex Therapeutics Ltd (SWX:ADXN)
Switzerland · Delayed Price · Currency is CHF 0.0236
-0.0008 (-3.28%)
Sep 11, 2026, 5:13 PM CET
Addex Therapeutics Market Cap
Addex Therapeutics has a market cap or net worth of 2.82 million as of September 11, 2026. Its market cap has decreased by -50.46% in one year.
Market Cap
2.82M
Enterprise Value
1.98M
Revenue
109.50K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
ChartMarket Cap Chart
Since May 22, 2007, Addex Therapeutics's market cap has decreased from 398.65M to 2.82M, a decrease of -99.29%. That is a compound annual growth rate of -22.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 2.82M | -56.40% |
| Dec 30, 2025 | 6.46M | 14.83% |
| Dec 30, 2024 | 5.62M | -9.01% |
| Dec 29, 2023 | 6.18M | -40.48% |
| Dec 30, 2022 | 10.39M | -73.65% |
| Dec 30, 2021 | 39.42M | -25.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.89B |
| Idorsia | 1.35B |
| Basilea Pharmaceutica AG | 804.70M |
| Santhera Pharmaceuticals Holding AG | 248.37M |
| Newron Pharmaceuticals | 246.34M |
| BioVersys AG | 160.71M |
| Molecular Partners AG | 132.54M |
| Xlife Sciences AG | 83.82M |